Pfizer Delays COVID Vaccine For Those Under Age 5

[broadstreet zone=”54526″]

WASHINGTON DC – Pfizer announced today, February 11, that parents will have to wait a little longer for a COVID vaccine for children under age 5.

Pfizer-BioNTech said it is postponing its application to the U.S. Food and Drug Administration to expand the use of its two-dose Covid-19 vaccine for children ages 6 months to 4 years.

The company said it still needs more data on the effects of a three-dose vaccine after two doses didn’t create a strong enough immune response.

[broadstreet zone=”58610″]

For infants, toddlers, & preschoolers, Pfizer’s vaccine has a dosage of 3 micrograms.

For children ages 5 to 11, the dosage is higher, at 10 micrograms.

Pfizer asked the FDA this month to authorize these first two doses, with a plan to submit additional data in the coming weeks on a third dose. The full vaccination series would be three doses.

More conclusive research is expected by early April, said Pfizer.